Flortaucipir F 18 (USAN); Flortaucipir (18F) (INN); Tauvid (TN)
Product
TAUVID (Eli Lilly and Company)
Formula
C16H10FN3
Exact mass
262.0884
Mol weight
263.2691
Structure
Remark
Product:
D11210<US>
Efficacy
Diagnostic aid
Comment
Imaging to distinctive characteristic of Alzheimer's disease in the brain called tau pathology.
Target
MAPT (TAU) [HSA:4137] [KO:K04380]
Pathway
hsa04010
MAPK signaling pathway
hsa05010
Alzheimer disease
Brite
Target-based classification of drugs [BR:br08310]
Not elsewhere classified
Cellular process
Cytoskeleton
MAPT (TAU)
D11210 Flortaucipir F 18 (USAN) <US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D11210
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D11210
Other DBs
CAS:
1522051-90-6
PubChem:
384585188
KCF data
ATOM 20
1 C8x C 22.1900 -9.8000
2 C8y C 22.1900 -11.2000
3 C8x C 23.4024 -11.9000
4 N5x N 24.6149 -11.2000
5 C8y C 24.6149 -9.8000
6 C8x C 23.4024 -9.1000
7 C8y C 20.9776 -11.9000
8 C8x C 19.7821 -11.2096
9 C8x C 18.5696 -11.9095
10 C8y C 18.5694 -13.3095
11 C8y C 19.7649 -13.9999
12 C8x C 20.9774 -13.3000
13 C8y C 17.5434 -14.2331
14 C8y C 18.1047 -15.4944
15 N4x N 19.4777 -15.3502
16 C8x C 16.1510 -14.0866
17 N5x N 15.3280 -15.2191
18 C8x C 15.8894 -16.4804
19 C8x C 17.2817 -16.6269
20 X F 25.8460 -9.0890
BOND 23
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 2 7 1
8 7 8 2
9 8 9 1
10 9 10 2
11 10 11 1
12 11 12 2
13 7 12 1
14 10 13 1
15 13 14 1
16 14 15 1
17 11 15 1
18 13 16 2
19 16 17 1
20 17 18 2
21 18 19 1
22 14 19 2
23 5 20 1